The acquisition of Creapharm by EP Finances in June 2013 paved the way for the creation of France’s largest pharmaceutical platform specialized in the management of clinical supplies.
The joint capabilities and expertise of the two sites strengthened the services offered to clients both in France and abroad, positioning us among the leading European clinical supplies vendors.
2 sites completely dedicated to the IMP/IVP management
From phase I to phase IV
33 years of expertise
67 employees including 8 project managers
More than 110 active clients
Close interaction two way communication
To date Creapharm and Sodia have successfully completed more than 10 000 clinical packaging runs and have made more than 250 000 worldwide shipments to investigational sites.
Agility – Creativity – Flexibility – Responsiveness
We also formulate and manufacture all kinds of pharmaceutical forms through our partner network.
No investment funds: Eric Placet holds 100% of the capital.